Clinical Evaluation of Human Granulocyte Colony-stimulating Factor in Chemotherapy for Ovarian Cancer

アクセス数 : 958
ダウンロード数 : 111

今月のアクセス数 : 3
今月のダウンロード数 : 0
File
HiroshimaJMedSci_44_99.pdf 448 KB 種類 : fulltext
Title ( eng )
Clinical Evaluation of Human Granulocyte Colony-stimulating Factor in Chemotherapy for Ovarian Cancer
Creator
Nagai Nobutaka
Takehara Kazuhiro
Murakami Takahiro
Ohama Koso
Miyaoka Shigeki
Fujii Tsuneo
Matsubayashi Shigeru
Source Title
Hiroshima Journal of Medical Sciences
Volume 44
Issue 4
Start Page 99
End Page 103
Journal Identifire
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
Abstract
The clinical evaluation of human granulocyte colony-stimulating factor (G-CSF) in 38 patients treated with chemotherapy for ovarian cancer stage III was investigated among 3 groups. G-CSF was not given in group A (19 courses), was administered from day 5 of chemotherapy in group B (53 courses), and was given when the WBC count decreased to below 2,000/mm3 in group C (29 courses).  

The time to nadir was significantly shorter in group B compared with groups A and C and revealed 10 days for the WBC count and 11 days for the neutrophil count (p<0.01), with mean nadir values of 2,896/mm3 and 982/mm3 respectively, and so the count of WBC and neutrophil have been kept during the course. The effect of G-CSF was not modified by age, body weight or the number of chemotherapy courses in groups B and C. These results demonstrate that early treatment with G-CSF may allow increased intensity of chemotherapy by using greater doses or by shortening of the interval between cycles.
Keywords
G-CSF
Ovarian cancer
Chemotherapy
NDC
Medical sciences [ 490 ]
Language
eng
Resource Type departmental bulletin paper
Publisher
Hiroshima University Medical Press
Date of Issued 1995-12
Publish Type Version of Record
Access Rights open access
Source Identifier
[ISSN] 0018-2052
[NCID] AA00664312